New injectables target Menopause-Related skin aging

NCT ID NCT07205744

Summary

This study is testing two different injectable treatments to improve skin concerns in post-menopausal women. Fifty women aged 40-65 will receive injections to address either skin dryness or laxity as their primary concern. Researchers will measure improvements in skin appearance, hydration, and elasticity to see which treatment approach works best.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AESTHETIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Erevna Innovations Inc.

    Montreal, Quebec, H3Z 1C3, Canada

Conditions

Explore the condition pages connected to this study.